Zions Bancorporation’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $3.2M | Buy |
40,996
+14,762
| +56% | +$1.15M | 0.2% | 98 |
|
|
2024
Q3 | $2.11M | Buy |
26,234
+4,278
| +19% | +$344K | 0.15% | 129 |
|
|
2024
Q2 | $1.82M | Buy |
21,956
+3,377
| +18% | +$279K | 0.15% | 117 |
|
|
2024
Q1 | $1.59M | Buy |
18,579
+963
| +5% | +$82.2K | 0.12% | 150 |
|
|
2023
Q4 | $1.51M | Buy |
17,616
+1,199
| +7% | +$103K | 0.1% | 152 |
|
|
2023
Q3 | $1.47M | Buy |
16,417
+2,311
| +16% | +$207K | 0.13% | 131 |
|
|
2023
Q2 | $1.2M | Buy |
14,106
+216
| +2% | +$18.4K | 0.1% | 160 |
|
|
2023
Q1 | $1.15M | Buy |
13,890
+1,547
| +13% | +$128K | 0.1% | 165 |
|
|
2022
Q4 | $971K | Buy |
12,343
+1,954
| +19% | +$154K | 0.08% | 169 |
|
|
2022
Q3 | $769K | Buy |
10,389
+13
| +0.1% | +$962 | 0.08% | 178 |
|
|
2022
Q2 | $676K | Buy |
10,376
+2,165
| +26% | +$141K | 0.07% | 208 |
|
|
2022
Q1 | $519K | Buy |
8,211
+2,377
| +41% | +$150K | 0.05% | 238 |
|
|
2021
Q4 | $309K | Buy |
5,834
+1,031
| +21% | +$54.6K | 0.03% | 273 |
|
|
2021
Q3 | $339K | Buy |
4,803
+705
| +17% | +$49.8K | 0.03% | 253 |
|
|
2021
Q2 | $273K | Buy |
4,098
+1,681
| +70% | +$112K | 0.03% | 264 |
|
|
2021
Q1 | $268K | Sell |
2,417
-11
| -0.5% | -$1.22K | 0.03% | 238 |
|
|
2020
Q4 | $288K | Buy |
2,428
+111
| +5% | +$13.2K | 0.04% | 207 |
|
|
2020
Q3 | $202K | Buy |
2,317
+1,294
| +126% | +$113K | 0.03% | 222 |
|
|
2020
Q2 | $92K | Buy |
1,023
+104
| +11% | +$9.35K | 0.01% | 281 |
|
|
2020
Q1 | $92K | Buy |
+919
| New | +$92K | 0.02% | 270 |
|